PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 186 filers reported holding PDL BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $88,000 | -36.2% | 26,000 | -37.0% | 0.06% | -32.6% |
| Q3 2016 | $138,000 | -42.3% | 41,300 | -45.7% | 0.09% | -21.2% |
| Q2 2016 | $239,000 | -5.5% | 76,000 | +0.1% | 0.11% | +21.5% |
| Q1 2016 | $253,000 | -5.9% | 75,900 | -0.1% | 0.09% | -9.7% |
| Q4 2015 | $269,000 | -7.6% | 76,000 | +31.5% | 0.10% | +60.9% |
| Q3 2015 | $291,000 | -36.5% | 57,811 | -18.8% | 0.06% | +1.6% |
| Q2 2015 | $458,000 | -7.1% | 71,200 | +1.6% | 0.06% | -4.5% |
| Q1 2015 | $493,000 | +2.5% | 70,100 | +12.3% | 0.07% | -33.3% |
| Q4 2014 | $481,000 | -7.3% | 62,400 | -10.2% | 0.10% | -12.4% |
| Q3 2014 | $519,000 | +107.6% | 69,500 | +169.4% | 0.11% | +109.3% |
| Q2 2014 | $250,000 | – | 25,800 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |